These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9018439)

  • 21. Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes.
    Selkirk SM; Greenberg SJ; Plunkett RJ; Barone TA; Lis A; Spence PO
    Gene Ther; 2002 Apr; 9(7):432-43. PubMed ID: 11938458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
    Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
    Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.
    Furlan R; Pluchino S; Martino G
    Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions.
    Uchitel J; Kantor B; Smith EC; Mikati MA
    Pediatr Neurol; 2020 Sep; 110():5-19. PubMed ID: 32684374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical issues in gene therapy for neurologic disease.
    Hsich G; Sena-Esteves M; Breakefield XO
    Hum Gene Ther; 2002 Mar; 13(5):579-604. PubMed ID: 11916483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration.
    Blits B; Boer GJ; Verhaagen J
    Cell Transplant; 2002; 11(6):593-613. PubMed ID: 12428749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy and neurodevelopmental disorders.
    Gray SJ
    Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor.
    Lin Q; Cunningham LA; Epstein LG; Pechan PA; Short MP; Fleet C; Bohn MC
    Hum Gene Ther; 1997 Feb; 8(3):331-9. PubMed ID: 9048200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HSV vector-mediated gene delivery to the central nervous system.
    Maguire-Zeiss KA; Bowers WJ; Federoff HJ
    Curr Opin Mol Ther; 2001 Oct; 3(5):482-90. PubMed ID: 11699893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for the nervous system: challenges and new strategies.
    Maguire CA; Ramirez SH; Merkel SF; Sena-Esteves M; Breakefield XO
    Neurotherapeutics; 2014 Oct; 11(4):817-39. PubMed ID: 25159276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards gene therapy for the central nervous system.
    During MJ; Ashenden LM
    Mol Med Today; 1998 Nov; 4(11):485-93. PubMed ID: 9857368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective viral vectors as agents for gene transfer in the nervous system.
    Kaplitt MG; Makimura H
    J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crossing the blood-brain-barrier with viral vectors.
    Fu H; McCarty DM
    Curr Opin Virol; 2016 Dec; 21():87-92. PubMed ID: 27591676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural stem cells -- a versatile tool for cell replacement and gene therapy in the central nervous system.
    Ourednik V; Ourednik J; Park KI; Snyder EY
    Clin Genet; 1999 Oct; 56(4):267-78. PubMed ID: 10636444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cells engineered to produce acetylcholine: therapeutic potential for Alzheimer's disease.
    Fisher LJ; Raymon HK; Gage FH
    Ann N Y Acad Sci; 1993 Sep; 695():278-84. PubMed ID: 8239296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy in the CNS.
    Costantini LC; Bakowska JC; Breakefield XO; Isacson O
    Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New strategies in neural repair.
    Tuszynski MH; Conner J; Blesch A; Smith D; Merrill DA; Vahlsing HL
    Prog Brain Res; 2002; 138():401-9. PubMed ID: 12432780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.